Peptides for Adrenal Fatigue and HPA Axis Recovery: Selank, DSIP, and BPC-157

Adrenal fatigue is a contested term in conventional medicine — most endocrinologists will tell you it is not a recognized diagnosis. Yet the symptom cluster it describes is real and common: chronic exhaustion despite adequate sleep, difficulty handling stress, reliance on caffeine, brain fog, disrupted sleep, and a pervasive sense of burnout. Whether the underlying issue is true adrenal insufficiency, HPA axis dysregulation, or burnout-related neuroendocrine changes, a growing number of people are exploring peptides as part of their recovery protocol.

This guide focuses on peptides with the strongest relevance to HPA axis function, cortisol modulation, and the neurological aspects of chronic stress and burnout.

Understanding HPA Axis Dysregulation

The hypothalamic-pituitary-adrenal (HPA) axis is the body's primary stress response system. When you encounter a stressor — physical, psychological, or inflammatory — the hypothalamus releases CRH (corticotropin-releasing hormone), which signals the pituitary to release ACTH, which then signals the adrenal cortex to produce cortisol.

In a healthy system, this response is self-limiting: rising cortisol provides negative feedback to the hypothalamus and pituitary, dampening further CRH and ACTH release. In chronic stress states, this feedback loop becomes dysregulated:

• Early phase: Elevated baseline cortisol, blunted cortisol awakening response, difficulty unwinding
• Prolonged phase: Flattened cortisol curve, reduced peak output, low morning cortisol, fatigue
• Associated changes: Altered sleep architecture, reduced GABA and serotonin tone, inflammatory dysregulation

Peptides relevant to this condition work by modulating GABA receptors, regulating stress neurotransmitters, normalizing sleep, and reducing inflammatory signaling that perpetuates HPA dysregulation.

Selank: Anxiolytic and HPA Modulator

Selank is a synthetic heptapeptide developed in Russia, derived from the immunomodulatory peptide tuftsin. It has been used in Russian clinical practice for anxiety disorders and cognitive impairment for decades, and has a more substantial clinical evidence base than most research peptides.

How Selank Affects Stress and the HPA Axis

GABAergic modulation. Selank increases GABA expression and enhances GABAergic tone in the brain. GABA is the primary inhibitory neurotransmitter, and its deficiency underlies much of the anxiety, hyperarousal, and sleep disruption associated with HPA dysregulation. Unlike benzodiazepines, selank's GABAergic effects do not appear to produce dependence or tolerance.

Serotonin regulation. Selank modulates serotonergic systems, supporting more stable mood and reduced anxiety without the receptor blunting associated with SSRIs.

Reduced IL-6 and inflammatory cytokines. Chronic HPA dysregulation is often accompanied by low-grade inflammation. Selank has demonstrated anti-inflammatory effects in animal models, reducing IL-6, IL-1β, and TNF-α — cytokines that perpetuate both HPA dysregulation and fatigue.

BDNF upregulation. Selank increases brain-derived neurotrophic factor (BDNF), supporting neuroplasticity and cognitive recovery — addressing the brain fog component of burnout.

Selank Protocol

• Dose: 250–500 mcg per administration
• Route: Intranasal (most common — drops or spray) or subcutaneous injection
• Frequency: 1–2 times daily
• Cycle: 10–14 days on, 10–14 days off (to prevent habituation)
• Best timing: Morning and/or early afternoon; avoid evening dosing if it is stimulating

The intranasal route is well-tolerated and avoids the need for injections. See our selank guide for full details.

DSIP: Delta Sleep-Inducing Peptide

DSIP (Delta Sleep-Inducing Peptide) is a nine-amino-acid neuropeptide first isolated in 1977 from rabbit cerebrospinal fluid following electrical stimulation. Its name reflects its most well-studied effect: the promotion of delta-wave (deep) sleep.

DSIP and HPA Axis Recovery

Sleep is the primary recovery window for HPA axis normalization. The cortisol awakening response — the sharp rise in cortisol that occurs in the first hour after waking — is dependent on adequate restorative sleep. Disrupted sleep architecture perpetuates HPA dysregulation in a vicious cycle.

DSIP addresses this cycle through several mechanisms:

Promotes delta-wave sleep. Delta sleep is the most restorative sleep stage for HPA axis recovery. DSIP specifically promotes slow-wave sleep without significantly altering REM or light sleep stages.

Normalizes cortisol secretion patterns. DSIP has been shown in research to normalize both elevated and blunted cortisol patterns, suggesting it has a regulatory (rather than simply suppressive) effect on the HPA axis.

Antioxidant effects. DSIP has documented antioxidant properties, relevant because chronic oxidative stress is both a consequence and a driver of HPA dysregulation.

Pain modulation. For people whose adrenal fatigue is partly driven by chronic pain keeping the stress response chronically activated, DSIP's mild analgesic effects may reduce this stimulus.

DSIP Protocol

• Dose: 100–600 mcg per injection
• Route: Subcutaneous injection
• Frequency: 3–5 evenings per week (not every night, to prevent tolerance)
• Timing: 30–60 minutes before bed
• Cycle: 2–4 week courses

See the full DSIP peptide guide for detailed information.

BPC-157: Gut-Brain-HPA Connection

BPC-157 is primarily known for tissue healing, but its relevance to HPA axis function is increasingly recognized. The gut-brain axis is bidirectional — chronic gut inflammation and intestinal permeability directly activate HPA stress responses. Many people with HPA dysregulation also have underlying gut issues.

BPC-157 and Stress Resilience

Dopamine and serotonin modulation. BPC-157 interacts with the dopaminergic and serotonergic systems in the CNS. Animal studies show it attenuates dopamine depletion caused by stress and reverses the behavioral effects of chronic stress exposure.

Gut-brain axis restoration. By healing the gut lining and reducing intestinal inflammation, BPC-157 reduces one of the major peripheral drivers of HPA hyperactivation — the inflammatory signaling from a compromised gut lining.

Anxiolytic-like effects. Multiple animal studies show BPC-157 produces anxiolytic and antidepressant-like effects through its modulation of CNS neurotransmitter systems, effects not seen with other tissue-repair peptides.

BPC-157 Protocol for HPA Support

• Dose: 250–500 mcg per injection or oral capsule
• Route: Oral (on empty stomach) for gut-brain axis effects, or subcutaneous for systemic
• Frequency: Once or twice daily
• Cycle: 6–8 weeks

Semax: Cognitive Recovery and Stress Resilience

Semax is a synthetic peptide analog of ACTH(4–7) — derived from the same molecule that drives cortisol production. Paradoxically, Semax does not stimulate HPA axis activity; instead it is neuroprotective and stress-resilience-promoting without raising cortisol.

Semax increases BDNF and NGF (nerve growth factor), supports dopamine and serotonin tone, and has been shown in clinical research to improve cognitive performance under stress conditions. It is particularly relevant for the cognitive symptoms of adrenal fatigue — brain fog, poor concentration, and mental fatigue. See the semax peptide guide.

A Comprehensive HPA Recovery Protocol

For someone dealing with significant HPA dysregulation, a layered approach using multiple complementary peptides is more effective than any single agent:

| Priority | Peptide | Purpose | |----------|---------|---------| | Core | Selank | Anxiolysis, GABA, BDNF, inflammation | | Sleep | DSIP | Deep sleep restoration, cortisol normalization | | Gut-brain | BPC-157 (oral) | Gut lining, CNS neurotransmitter support | | Cognitive | Semax (intranasal) | BDNF, focus, stress resilience |

Sample schedule:

• Morning: Selank (intranasal) + Semax (intranasal)
• Day: BPC-157 oral capsule on empty stomach
• Evening: DSIP (SC injection before bed)

Run for 4–6 weeks, then take a 2-week break before repeating if needed.

Lifestyle Foundations That Peptides Cannot Replace

Peptides support the biological side of HPA recovery, but the drivers of dysregulation must also be addressed:

• Sleep hygiene: Consistent wake time, dark room, minimal blue light after sunset
• Stress load reduction: Where possible, reduce or restructure the chronic stressors driving HPA activation
• Nutrition: Adequate carbohydrate intake (very low carb diets can increase cortisol); regular meal timing
• Exercise: Moderate-intensity exercise supports HPA recovery; high-intensity training (especially without adequate recovery) can worsen it
• Social connection: Among the most powerful modulators of HPA tone, chronically undervalued in self-optimization discussions

Frequently Asked Questions

Q: Is adrenal fatigue a real medical condition? As a distinct clinical entity defined by blunted adrenal output without Addison's disease, it is not recognized by mainstream endocrinology. The underlying phenomena — HPA axis dysregulation, altered cortisol patterning, and chronic burnout — are real and measurable. These peptides address the broader neuroendocrine and neurological aspects of chronic stress rather than the adrenal gland specifically.

Q: How long does HPA axis recovery take with peptides? Most people notice improved sleep quality within 1–2 weeks of DSIP use. Subjective improvements in energy, anxiety, and stress tolerance with selank typically appear within days to weeks. Meaningful HPA axis normalization is a process measured in months, not weeks.

Q: Can I use selank and DSIP together? Yes. They work through different mechanisms and target different aspects of HPA recovery. Selank during the day addresses anxiety and inflammatory signaling; DSIP in the evening addresses sleep architecture. There is no known interaction between them.

Q: Will DSIP make me groggy the next day? At doses below 600 mcg, most users report improved sleep quality without next-day sedation. Some users find even lower doses (100–200 mcg) fully effective. Start low and adjust.

Q: Are there any peptides I should avoid if I have HPA dysregulation? GH-stimulating peptides like CJC-1295 and ipamorelin have cortisol-neutral or mildly cortisol-reducing effects and are generally well-tolerated in people with HPA dysregulation. High-dose GHRP-6 can elevate cortisol — use GHRP-2 or ipamorelin instead if GH peptides are desired. Avoid anything with stimulant properties during an HPA recovery period.

Q: Can I check cortisol levels to monitor my progress? Yes. A four-point salivary cortisol test (collected at waking, 12pm, 5pm, and bedtime) provides a picture of the diurnal cortisol curve. This is more informative than a single blood cortisol measurement, which captures only one point and fluctuates rapidly. Testing before and after a peptide protocol gives objective data on whether the cortisol pattern has normalized.